Oversold

CAT

Valuation18/ 100
Cash flow & growth67/ 100
Upside potential41/ 100
Risk potential29/ 100

CAT's valuation is expensive, fundamentals are above averages and forward estimates point to improving growth and profitability.

Score change since last week

The score fell 1 point, mainly due to valuation and price changes. Price rose 1.7%, from $800.25 to $813.94. Reported EPS was unchanged, so the higher price reduced valuation support.

The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 35.2× versus the full-history median of 17.2× shown in the valuation table, producing 13.9/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 17.5/100. The model applies a 28.6% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 19.4× (18-month half-life). The favorable scenario uses 30.5× PE and $32.2 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are strong. Over the past year: revenue +18.4%, earnings +18.3%, operating margin -0.8 percentage points. Free cash flow is 12% of revenue. The business score is 67.4/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $32.19 of EPS and a 30.5× PE, suggesting a share price of about $983.33. Valuation history and outlook inform the PE.

The displayed favorable scenario is 20.1% upside, or about $983.10.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $20.24 of EPS and a 28.7× PE, suggesting a share price of about $580.07 — 29% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

CAT vs Historical averages

MetricCurrentAverageRelative
PE35x21x68% higher
PE percentile885077% higher
EPS$23.25$15.0455% higher
FCF$9B$6.8B32% higher
Loading historical comparisons…

CAT’s earnings and cash flow are above their historical averages, while its earnings multiple is higher.

CAT Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsStrong growth
Forward revenueGrowth
Forward profitabilityExpanding
Analyst coverageModerate
Estimate dispersionModerate

CAT’s outlook is generally improving, with growth expectations supporting the valuation case.

CAT PE Valuation

Loading pe valuation table…

This table applies CAT's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

CAT Earnings Per Share

Loading earnings per share…

This chart tracks CAT's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

CAT Quarterly Revenue

Loading quarterly revenue…

This chart tracks CAT's quarterly revenue over time and shows how sales are changing from year to year.

CAT Free Cash Flow

Loading free cash flow…

This chart tracks CAT's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

CAT Total Shares

Loading shares over time…

This chart tracks changes in CAT's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

CAT Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

CAT PE vs Industrials Sector

Loading pe vs sector average…

This chart compares CAT's price-to-earnings (PE) ratio with the Industrials sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

CAT Weekly Price

Loading weekly price…

This chart uses CAT's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

CAT Weekly Moving Averages

Loading weekly moving averages…

This chart compares CAT's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

CAT Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.

FCN

Valuation66/ 100
Cash flow & growth64/ 100
Upside potential66/ 100
Risk potential19/ 100

FCN's valuation is attractive, fundamentals are above averages and forward estimates point to improving growth and profitability, though analyst coverage is limited.

Score change since last week

The score rose 1 point, mainly due to valuation and price changes. Price fell 1.3%, from $153.74 to $151.70. Reported EPS was unchanged, so the lower price improved valuation support.

Valuation and price changes added 1.7 points. The comparison uses the same available inputs on both dates. Displayed changes are rounded to whole points.

Valuation

Historical cheapness: current PE is 18.3× versus the full-history median of 22.2× shown in the valuation table, producing 63/100. Positive weekly observations receive equal weight; lower past EPS alone does not disqualify them.

Outlook-adjusted valuation: 66.4/100. The model applies a 18.9% earnings-growth assumption and a 10% annual return hurdle, with positive credit limited by evidence coverage and confidence.

Forward price scenarios use recent PE history separately. Recent history has a separately weighted median of 22.1× (18-month half-life). The favorable scenario uses 20.6× PE and $10.4 projected EPS, informed by growth, margins and earnings-quality checks. This is a model scenario, not an analyst target. A return to the full-history median is not assumed.

Cash flow & growth

Business trends are mixed. Over the past year: revenue +7.1%, earnings +13.9%, operating margin +0.2 percentage points. Free cash flow is 10.6% of revenue. The business score is 63.6/100. Growth, margins and cash generation drive the score. Missing or older data receives less weight.

Favorable scenario

Stronger earnings and valuation could support a higher share price.

Our favorable case uses $10.40 of EPS and a 20.6× PE, suggesting a share price of about $213.87. Valuation history and outlook inform the PE.

The displayed favorable scenario is 44.4% upside, or about $213.81.

This is a scenario based on our model, not a forecast or probability.

Downside scenario

Weaker than expected earnings could put pressure on the share price.

Our downside case uses $6.91 of EPS and a 17.4× PE, suggesting a share price of about $120.21 — 19% below today’s price. Valuation history and outlook inform the PE.

This is a scenario based on our model, not a forecast or probability.

FCN vs Historical averages

MetricCurrentAverageRelative
PE18x23x21% lower
PE percentile3.75093% lower
EPS$8.09$7.2212% higher
FCF$415.6M$200.5M107% higher
Loading historical comparisons…

FCN’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.

FCN Forward outlook

MetricOutlook
Forward valuationImproving
Forward earningsStrong growth
Forward revenueGrowth
Forward profitabilityExpanding
Analyst coverageLimited
Estimate dispersionTight

FCN’s outlook is generally improving, though analyst coverage is limited.

FCN PE Valuation

Loading pe valuation table…

This table applies FCN's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.

FCN Earnings Per Share

Loading earnings per share…

This chart tracks FCN's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.

FCN Quarterly Revenue

Loading quarterly revenue…

This chart tracks FCN's quarterly revenue over time and shows how sales are changing from year to year.

FCN Free Cash Flow

Loading free cash flow…

This chart tracks FCN's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.

FCN Total Shares

Loading shares over time…

This chart tracks changes in FCN's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.

FCN Net Leverage

Loading net leverage…

Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.

FCN PE vs Industrials Sector

Loading pe vs sector average…

This chart compares FCN's price-to-earnings (PE) ratio with the Industrials sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.

FCN Weekly Price

Loading weekly price…

This chart uses FCN's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.

FCN Weekly Moving Averages

Loading weekly moving averages…

This chart compares FCN's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.

FCN Yearly ROI

Loading yearly ROI…

Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.